Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Link Aktie 44955994 / JP3977010002

17.06.2026 01:04:51

DTCC And Stellar Plan Tokenization Link For DTC-Custodied Assets

TL;DRDTCC and the Stellar Development Foundation announced a planned tokenization collaboration on May 27, 2026.The project aims to connect DTCC’s tokenization service with Stellar for DTC-custodied assets.Initial use cases include liquid equities, ETF trackers, and US Treasury securities.The integration is expected in the first half of 2027 and should not be described as live Wall Street settlement today.DTCC and the Stellar Development Foundation are moving toward a tokenization link that could bring selected DTC-custodied traditional assets onto blockchain rails, but the key word for traders is “planned.” This is a future integration, not an immediate live settlement overhaul of Wall Street.According to the June 16 writing handoff, the collaboration was announced on May 27, 2026, and would connect DTCC’s tokenization service to the Stellar network. The initial focus is expected to be on highly liquid assets, including Russell 1000 constituents, ETF index trackers, and US Treasury bills, notes, and bonds.Why Stellar Is Back In The Institutional ConversationStellar has long positioned itself around payments, asset issuance, and compliance-friendly token movement rather than purely speculative DeFi. That makes the DTCC connection notable because tokenizing DTC-custodied assets requires more than fast block times. It requires controls, permissions, and clear operating frameworks that traditional market infrastructure can understand.The handoff also notes that the pilot is tied to an SEC no-action letter issued in December 2025, supporting a three-year pilot program for tokenizing DTC-custodied traditional securities. That gives the story a regulatory structure rather than just a marketing angle.The Caveat: This Is Not Live Settlement YetThe biggest risk in covering the story is overstating it. DTCC has not suddenly moved Wall Street settlement onto Stellar. The integration is scheduled for the first half of 2027, and the source packet frames it as part of a broader multi-chain strategy. That means the correct read is institutional experimentation moving toward production, not a finished migration.For XLM and RWA traders, though, the story still matters. Real-world asset tokenization has often been dominated by newer networks and private enterprise platforms. Stellar being included in a DTCC-linked initiative gives the older network a fresh institutional narrative and may lead traders to reassess where compliance-heavy tokenization demand could land over the next cycle.The market will now be watching whether this planned link becomes a functional product in 2027 or remains another tokenization pilot that never reaches meaningful volume.Why The Timeline MattersThe H1 2027 timing gives markets a clear checkpoint. Between now and then, the important developments will be technical integration updates, participating asset lists, regulatory boundaries, and whether other chains are added alongside Stellar. If the pilot advances smoothly, it could strengthen the case for public-chain involvement in institutional asset workflows. If it slips or remains narrowly scoped, the tokenization narrative may stay more symbolic than market-moving for XLM in the near term.That makes the story useful as an evening draft because it gives readers a clear market takeaway rather than a simple headline rewrite. The important point is not only what happened, but what traders should monitor next: confirmation from primary sources, whether the initial reaction holds, and whether the development creates lasting liquidity, regulatory, or risk-management implications.This article was written by the News Desk and edited by Samuel Rae.Weiter zum vollständigen Artikel bei NewsBTC
In eigener Sache

Trading Signals: BB Biotech: Comeback nimmt Fahrt auf

Der heimische Biotech-Investor überzeugt nicht nur mit starken Quartalszahlen: Auch schlägt das Portfolio den Branchenindex deutlich, während die Aktie dem inneren Wert noch hinterherhinkt. Genau darin liegt weiteres Kurspotenzial.

Weiterlesen!

Analysen zu Link Inc. Registered Shs

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio

Im BX Morningcall werden folgende Aktien analysiert und erklärt
✅ Wabtec
✅ Eli Lilly
✅ Novartis

https://bxplus.ch/bx-musterportfolio/

Wabtec, Eli Lilly und Novartis neu im BX Musterportfolio

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 15’172.10 19.89 SKUBAU
Short 15’483.24 13.89 SQZB4U
Short 16’050.35 8.99 S7WB3U
SMI-Kurs: 14’552.30 07.08.2026 17:30:00
Long 13’970.23 19.10 S7BGFU
Long 13’678.45 13.83 SCB0YU
Long 13’088.65 8.91 SVB5UU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com